Latest News and Press Releases

MALVERN, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for...

Annovis attends CTAD 2025 with two presentations highlighting new biomarker data in Alzheimer's and Parkinson's diseases.

PALM BEACH, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The precision oncology sector is experiencing unprecedented transformation as biomarker-driven therapies and...

NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and...

Buntanetap significantly improves cognition in all Parkinson’s patients, with those exhibiting Alzheimer’s co-pathology showing a three-times greater response New data demonstrate reductions in...

Boston, Nov. 05, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Biomarker Deals: Terms Value and Trends 2019-2025” reflect shifting investment priorities and growing...

EXTON, PA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Spherix Global Insights has released a new white paper, Navigating the Evolving SLE/Lupus Nephritis Landscape: Keys to Successful Product Launches, which...

ATLANTA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Countdown For A Cure, a foundation dedicated to accelerating mitochondrial research and medicine, today announced a $350,000 grant to Minovia Therapeutics...

Delray Beach, FL, June 23, 2025 (GLOBE NEWSWIRE) -- The global biomarkers market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR...

SplashBIO™: A biomarker platform for clinical trials that uses biomarker tests to accelerate enrollment, save money, and reduce screen failure rates.